Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011344) titled 'Safety and efficacy evaluation study of Varabom. D to help screen patients with mild cognitive impairment' on Dec. 18, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Screening, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: Yonsei University Health System, Gangnam Severance Hospital
Condition:
Mental and behavioural disorders
Intervention:
Medical Device : 1. Study Population: The target population consists of individuals undergoing screening for mild cognitive impairment using a virtual reality cognitive assessment program.
2. Key Intervent...